-transparent.png){kind=logo}
Somatostatin receptor scintigraphy in non-medullary thyroid cancer. 1996
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
Department of Internal Medicine III, University Hospital, Rotterdam, The Netherlands.
8 patients with papillary cancer (4 with metastases, 4 in remission), 7 follicular cancer patients (6 with metastases), 2 patients with anaplastic thyroid cancer and 4 other non-medullary thyroid cancer patients all received an intravenous bolus injection of 220 MBq [111In-DTPA-D-Phe1]octreotide. Planar anterior and posterior gamma camera images of head-neck, chest and abdomen were obtained 24 and 48 h after injection. All primary cancers showed [111In-DTPA-D-Phe1] octreotide uptake; none occurred in patients in remission. The results were compared with conventional radio-iodine scintigraphy in patients with metastasised, differentiated thyroid cancer.
Related Publications
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
April 1997,
The British journal of surgery,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
January 1999,
Nuklearmedizin. Nuclear medicine,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
January 2012,
Hormones (Athens, Greece),
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
June 1993,
Nuclear medicine communications,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
February 1995,
Nuklearmedizin. Nuclear medicine,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
October 2007,
European journal of nuclear medicine and molecular imaging,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
June 1998,
Thyroid : official journal of the American Thyroid Association,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
January 1993,
Hormone and metabolic research. Supplement series,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
May 1994,
Clinical nuclear medicine,
P T Postema, and
W W De Herder, and
J C Reubi, and
H Y Oei, and
D J Kwekkeboom, and
H J Bruining, and
J Bonjer, and
H van Toor, and
G Hennemann, and
E P Krenning
December 1995,
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR),
